Review Article

Understanding and Improving 18F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate Cancer

Figure 6

Images of an 80-year-old male who had received robotic-assisted laparoscopic prostatectomy and salvage radiation therapy. He was referred for 18F-fluciclovine imaging with PSA rising to 1.1 ng/mL. Top row: The axial, fused PET/CT image on the left identifies a focus of mildly enhanced 18F-fluciclovine uptake (white arrow) at the level of the common iliac vessels. The corresponding CT image on the right identifies 2 small, 5-mm lymph nodes (yellow arrow). Bottom row: note the 18F-fluciclovine-avid lesion in the body of T12 (white arrow, left-hand image), with the corresponding CT view on the right demonstrating the lesion at the identical location (yellow arrow).
(a)
(b)